Myotonic Dystrophy 1

Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension

A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1

An Ambispective Natural History Study in Myotonic Dystrophy Patients Linking Retrospective Data Captured From the DM-Scope Registry With a Prospective 24-month Follow-up Period

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (C-DMCOS-DM1)

Myotonic Dystrophy - Vascular and Cognition

An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)

Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients

Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1

Study of ATX-01 in Participants With DM1

The Spanish National Registry for Myotonic Dystrophy Type 1

Global Study of Del-desiran for the Treatment of DM1

Calcium Channel Blocker in Myotonic Dystrophy Type 1

Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)

Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy

Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients

Venous Thromboembolism in Myotonic Dystrophy Type 1

Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology